ClinicalTrials.Veeva

Menu

A Critical Illness Recovery Navigator for Alcohol (CIRNA)

University of Colorado Denver (CU Denver) logo

University of Colorado Denver (CU Denver)

Status

Terminated

Conditions

Alcohol Use Disorder (AUD)

Treatments

Behavioral: Recovery Navigator prior to hospital discharge
Behavioral: Recovery Navigator on an as needed basis up to 6 months
Other: No interaction with Recovery Navigator

Study type

Interventional

Funder types

Other

Identifiers

NCT03059082
16-2094

Details and patient eligibility

About

Excessive alcohol consumption is common in patients admitted to the intensive care unit (ICU). Among patients who survive an ICU admission, excessive alcohol consumption is associated with a higher risk of being admitted the hospital. In this study, the Investigators will compare an intervention designed to address excessive drinking in ICU survivors to usual care. This intervention combines motivational interviewing (MI) and shared decision making (SDM). MI and SDM share several core components including the development of a therapeutic alliance and promotion of autonomy. MI can be employed in the context of motivating a patient to change their drinking. Once this decision has been made, SDM can be employed to help a patient decide amongst multiple reasonable treatment options. The Investigators long-term goal is to test whether MI-SDM is better than usual care and whether multiple sessions of MI-SDM are better than a single session. This pilot clinical trial will demonstrate the feasibility of conducting a larger efficacy study to test these hypotheses.

Enrollment

47 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Admission to the intensive care unit;

  2. Age 18 years or older;

  3. Resolution of critical illness, defined as the intention of the treating team to discharge the patient or downgrade their admission level from the ICU to a progressive care unit or the floor;

  4. Resolution of delirium, defined by:

    • a Riker Agitation Sedation Scale score of 0,
    • a negative CAM ICU, and
    • confirmation from the treating team (nurse, physicians) that the patient is not delirious.
  5. AUDIT-C score of 3 or greater for women and 4 or greater for men.

Exclusion criteria

  1. Prisoner;
  2. Pregnant;
  3. Unable to speak or write in English;
  4. Unable to provide informed consent;
  5. Unable to provide a home or cell phone number plus at least one additional way to be contacted (mail, email, friend or family);
  6. Expected survival less than 6 months.

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

47 participants in 3 patient groups

Continued Interaction
Other group
Description:
This group will undergo contact with Recovery Navigator on an "as needed basis" up to 6 months.They will then have a 3 month and 6 month follow up visit with the PI. There is no drug or treatment administered to the subject. The intervention is the conversation/contact with the Recovery Navigator, in this arm, it is continued throughout the study. Note: The first 10 subjects will not be randomized and will be assigned to this Arm. The purpose of this is to ensure the fidelity of the intervention. The remaining 60 subjects will be randomized equally among the three Arms. Data from the first 10 subjects will not be considered for the outcome measures.
Treatment:
Behavioral: Recovery Navigator on an as needed basis up to 6 months
Single interaction
Other group
Description:
This group will undergo one interaction with the Recovery Navigator prior to the hospital discharge. They will then have a 3 month and 6 month follow up visit with the PI. There is no drug or treatment administered to the subject.The intervention is the conversation/contact with the Recovery Navigator, in this arm, it is conducted once.
Treatment:
Behavioral: Recovery Navigator prior to hospital discharge
Control
Other group
Description:
This group will not have any interaction with the Recovery Navigator. They will then have a 3 month and 6 month follow up visit. There is no drug or treatment administered to the subject.
Treatment:
Other: No interaction with Recovery Navigator

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems